Neuropsychiatric presentations of antiphospholipid antibodies

Thrombosis Research

Volumn 135, Issue S1, 2015, Pages S56-S59

  Gris, Jean Christophe ^a   Nobile, Benédicte ^a   Bouvier, Sylvie ^a  

^a NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Neurology; Psychiatry

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; COGNITIVE DEFECT; DEMENTIA; HUMAN; MENTAL DISEASE; MULTIPLE SCLEROSIS; NEUROLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHIATRY; ANIMAL; BRAIN DISEASES; IMMUNOLOGY; MENTAL DISORDERS;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BRAIN DISEASES; HUMANS; MENTAL DISORDERS;

EID: 84923009642     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(15)50445-3     Document Type: Article

References (28)

1. S. Miyakis, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, R. Cervera, R.H. Derksen, P.G. de Groot, T. Koike, P.L. Meroni, G. Reber, Y. Shoenfeld, A. Tincani, P.G. Vlachoyiannopoulos, and S.A. Krilis International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 306
2. G.R. Hughes Thrombosis, abortion, cerebral disease, and the lupus anticoagulant Br Med J (Clin Res Ed) 287 1983 1088 1089
3. M.G. Tektonidou, N. Varsou, G. Kotoulas, A. Antoniou, and H.M. Moutsopoulos Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings Arch Intern Med 166 2006 2278 2284
4. A. Katzav, Y. Shoenfeld, and J. Chapman The pathogenesis of neural injury in animal models of the antiphospholipid syndrome Clin Rev Allergy Immunol 38 2010 196 200
5. L. Ziporen, S. Polak-Charcon, D.A. Korczyn, I. Goldberg, A. Afek, J. Kopolovic, J. Chapman, and Y. Shoenfeld Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model Clin Dev Immunol 11 2004 67 75
6. D. Tanne, A. Katzav, O. Beilin, N.C. Grigoriadis, M. Blank, C.G. Pick, Landenberg Pv, Y. Shoenfeld, and J. Chapman Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome Neurobiol Dis 30 2008 56 64
7. P.S. Rajput, P.D. Lyden, B. Chen, J.A. Lamb, B. Pereira, A. Lamb, L. Zhao, I.F. Lei, and J. Bai Protease Activated Receptor-1 mediates cytotoxicity during ischemia using in vivo and in vitro models Neuroscience. 281C 2014 229 240
8. J. Chapman, M. Cohen-Armon, Y. Shoenfeld, and A.D. Korczyn Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes Lupus 8 1999 127 133
9. J.H. Griffin, B.V. Zlokovic, and L.O. Mosnier Protein C anticoagulant and cytoprotective pathways Int J Hematol 95 2012 333 345
10. A.E. Gharavi, L.R. Sammaritano, J. Wen, and K.B. Elkon Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H) J Clin Invest 90 1992 1105 1109
11. M. Blank, D. Faden, A. Tincani, J. Kopolovic, I. Goldberg, B. Gilburd, F. Allegri, G. Balestrieri, G. Valesini, and Y. Shoenfeld Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice J Autoimmun 7 1994 441 455
12. A. Katzav, C.G. Pick, A.D. Korczyn, E. Oest, M. Blank, Y. Shoenfeld, and J. Chapman Hyperactivity in a mouse model of the antiphospholipid syndrome Lupus 10 2001 496 499
13. L. Ziporen, Y. Shoenfeld, Y. Levy, and A.D. Korczyn Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model J Clin Invest 100 1997 613 619
14. Y. Shoenfeld, A. Nahum, A.D. Korczyn, M. Dano, R. Rabinowitz, O. Beilin, C.G. Pick, L. Leider-Trejo, L. Kalashnikova, M. Blank, and J. Chapman Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer Lupus 12 2003 436 442
15. K. Frauenknecht, A. Katzav, R. Weiss Lavi, A. Sabag, S. Otten, J. Chapman, and C.J. Sommer Mice with experimental antiphospholipid syndrome display hippocampal dysfunction and a reduction of dendritic complexity in hippocampal CA1 neurons Neuropathol Appl Neurobiol 2014 Sep 9 10.1111/nan.12180 [Epub ahead of print]
16. M.W. Jacobson, L.J. Rapport, P.A. Keenan, R.D. Coleman, and G.E. Tietjen Neuropsychological deficits associated with antiphospholipid antibodies J Clin Exp Neuropsychol 21 1999 251 264
17. A. Mosek, I. Yust, T.A. Treves, N. Vardinon, A.D. Korczyn, and J. Chapman Dementia and antiphospholipid antibodies Dement Geriatr Cogn Disord 11 2000 36 38
18. R. Schmidt, P. Auer-Grumbach, F. Fazekas, H. Offenbacher, and P. Kapeller Anticardiolipin antibodies in normal subjects Neuropsychological correlates and MRI findings. Stroke 26 5 1995 749 754
19. D.A. Whitelaw, J.J. Spangenberg, R. Rickman, F.H. Hugo, and M. Roberts The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE Lupus 8 1999 444 448
20. C.H. Kao, J.L. Lan, J.F. Hsieh, Y.J. Ho, S.P. ChangLai, J.K. Lee, and H.J. Ding Evaluation of regional cerebral blood flow with 99mTc-HMPAO in primary antiphospholipid antibody syndrome J Nucl Med 40 1999 1446 1450
21. M. Maes, H. Meltzer, J. Jacobs, E. Suy, J. Calabrese, B. Minner, and J. Raus Autoimmunity in depression: increased antiphospholipid autoantibodies Acta Psychiatr Scand 87 1993 160 166
22. J.N. Avari, and R.C. Young A patient with bipolar disorder and antiphospholipid syndrome J Geriatr Psychiatry Neurol 25 2012 26 28
23. A.C. Spyropoulou, E.I. Tsartsara, A. Angelopoulou, and I.M. Zervas Psychiatric manifestations preceding fetal death in antiphospholipid syndrome Gen Hosp Psychiatry 32 2 2010 225 227
24. A. Delluc, A. Rousseau, M. Le Galudec, O. Canceil, B. Woodhams, S. Etienne, M. Walter, D. Mottier, P. Van Dreden, and K. Lacut Prevalence of antiphospholipid antibodies in psychiatric patients users and non-users of antipsychotics Br J Haematol 164 2014 272 279
25. D.K. Sokol, R.S. O'Brien, D.R. Wagenknecht, T. Rao, and J.A. McIntyre Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis J Neuroimmunol 190 1-2 2007 151 156
26. G.K. Bertsias, J.P. Ioannidis, M. Aringer, E. Bollen, S. Bombardieri, I.N. Bruce, R. Cervera, M. Dalakas, A. Doria, J.G. Hanly, T.W. Huizinga, D. Isenberg, C. Kallenberg, J.C. Piette, M. Schneider, N. Scolding, J. Smolen, A. Stara, I. Tassiulas, M. Tektonidou, A. Tincani, M.A. van Buchem, R. van Vollenhoven, M. Ward, C. Gordon, and D.T. Boumpas EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs Ann Rheum Dis 69 2010 2074 2082
27. A. Tourbah, A. Clapin, O. Gout, B. Fontaine, R. Liblau, F. Batteux, J.L. Stiévenart, B. Weill, C. Lubetzki, and O. Lyon-Caen Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study Arch Neurol 55 4 1998 517 521
28. J.Y. Lai, P.C. Wu, H.C. Chen, and M.B. Lee Early neuropsychiatric involvement in antiphospholipid syndrome Gen Hosp Psychiatry 34 579 2012 e1 e3